Quantcast
Last updated on April 23, 2014 at 10:44 EDT

Latest urge incontinence Stories

2014-02-26 08:28:02

MINNEAPOLIS, Feb. 26, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 26th Annual ROTH Conference on Tuesday, March 11, 2014. Rob Kill, President and CEO, and Brett Reynolds, Chief Financial Officer, will present at 8:30am PT and meet with investors one on one at the conference at the Ritz...

2014-02-06 08:27:59

~Positive Coverage Decision Adds 2.2 Million Covered Lives for Up to Two Years of Treatment with Urgent PC MINNEAPOLIS, Feb. 6, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Independence Blue Cross (IBC) has written a positive coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) delivered via Uroplasty's...

2014-01-27 16:25:04

Experienced Executive in Development and Commercialization of Medical Devices to Assume Key New Position MINNEAPOLIS, Jan. 27, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it has appointed Dr. Suranjan Roychowdhury as Vice President of Research & Development and Clinical Affairs. This newly created position within...

2014-01-09 16:25:03

MINNEAPOLIS, Jan. 9, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) announced today that it will release financial results for the third quarter of fiscal 2014 ended December 31, 2013 at the market close on Thursday, January 23, 2014. The Company will host a conference call and webcast to discuss these results on Thursday, January 23, 2014 at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). Rob Kill, President and Chief Executive Officer, and Brett Reynolds, Chief Financial...

2013-12-23 08:26:09

~Positive Coverage Decision Adds 2.7 Million Covered Lives for Urgent PC MINNEAPOLIS, Dec. 23, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Medical Mutual has written a positive coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) delivered via Uroplasty's Urgent(®) PC Neuromodulation System for treatment...

2013-12-18 23:26:38

Urinary incontinence, or bladder leakage, affects up to 30 million American women. The Woodlands, Texas (PRWEB) December 18, 2013 Symptoms of stress incontinence include leakage that occurs after coughing, sneezing, laughing, or during exercise and is often related to weakened pelvic floor muscles. Symptoms of urge incontinence include a strong, sudden need to urinate due to bladder spasms or contractions. InTone® is the first medical device that combines muscle stimulation and...

2013-12-10 08:29:41

Seasoned Executive Adds Expertise in Developing, Branding and Commercializing Medical Device Products to UPI Team MINNEAPOLIS, Dec. 10, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that David B. Perry has joined the Company as Vice President of Marketing. He joins Uroplasty with nearly 20 years of experience developing,...

2013-12-05 23:27:57

Urinary incontinence, or bladder leakage, affects up to 30 million American women. New York, New York (PRWEB) December 05, 2013 Symptoms of stress incontinence include leakage that occurs after coughing, sneezing, laughing, or during exercise and is often related to weakened pelvic floor muscles. Symptoms of urge incontinence include a strong, sudden need to urinate due to bladder spasms or contractions. InTone® is the first medical device that combines muscle stimulation and...

2013-12-04 08:29:02

Company Expects to End 2013 with Procedure Coverage for More Than 140 Million Lives, Up from 124 Million Lives as of 12/31/2012 MINNEAPOLIS, Dec. 4, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today provided an update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation (PTNS) procedures delivered via the Company's...

2013-11-21 08:26:42

MINNEAPOLIS, Nov. 21, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013. Rob Kill, President and CEO, and Brett Reynolds, Chief Financial Officer, will present at 3:30pm ET and meet with investors one on one at the...